August 10, 2021

Immunization Program Policy Resource Guide: Chapter 2

Chapter 2 of the Resource Guide discusses the key players that shape the immunization policy landscape in your state, highlights the benefits of partnering with them, and offers suggestions for building effective relationships.
August 2, 2021

Vaccine Confidence Toolkit Resource Guide: Chapter 1

Chapter 1 of the Vaccine Confidence Resource Guide highlights IP experiences, lessons learned, and resources to help IPs minimize the impact of vocal vaccine opposition during legislative and rulemaking processes and maximize efforts to inform policymakers of the value of immunization. Helpful tools include the Checklist for Engaging in the Legislative Process, Addressing Medical Freedom Arguments, and a Build Your Own Q&A Document.
April 28, 2021

Back to School/Catch-Up Immunization Webinar

AIM hosted a Back to School/Catch-Up Immunization webinar with partners from CDC, Unity Consortium, National Association of School Nurses (NASN), and Immunize Nevada…

April 21, 2021

HHS Fact Sheet on Vaccine Ingredients

Vaccine ingredient facts from a federal government Website managed by the Office of Infectious Disease and HIV/AIDS Policy, U.S. Department of Health and…

April 16, 2021

Rhode Island House Bill 6015

The bill would require immunization informed consent forms to include information on the vaccine’s manufacturing details, potential adverse reactions, vaccine ingredients, and contraindications.…

April 8, 2021

CT Legislator Questions about Exemptions

On February 19, 2020, the Connecticut General Assembly’s Public Health Committee held a hearing on House Bill 5044, which would eliminate religious exemptions…

March 9, 2021

Summary: The Value of Vaccines Report

Notes from AIM staff on the Value of Vaccines report which summarizes recent evidence demonstrating how vaccines provide incredible value in more ways…

March 8, 2021

ROI Brief – The Value of Vaccine Programs

Digestible brief from Johns Hopkins Bloomberg School of Public Health and the International Vaccine Access Center on new return on investment estimates from…

Back To Top